Search Results for ASCO

Showing 1 – 4

Regulatory Recon: Loxo's Targeted Cancer Drug Sees High Response Rate & More News From ASCO17 (5 June 2017) By Michael Mezher - Published 05 June 2017

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.

Categories: News, Biologics and biotechnology, Drugs, Medical Devices, Regulatory intelligence

Tags: Regulatory Reconnaissance, Regulatory, Links, News, Regulatory News, Regulatory Intelligence, FDA News, EMA News, ASCO, ASCO17

Regulatory Recon: FDA Expands Use of CF Drug; ASCO Abstracts Released (18 May 2017) By Zachary Brennan - Published 18 May 2017

Welcome to Regulatory Recon, a daily regulatory news and intelligence briefing.

Categories: Canada, Europe, US, FDA, Health Canada, Biologics and biotechnology, Drugs, Medical Devices

Tags: ASCO, Regulatory Reconnaissance, Regulatory, Links, News, Regulatory News, Regulatory Intelligence, FDA News, EMA News

Promotional Materials at ASCO Land Jazz Subsidiary FDA's Third Untitled Letter of 2016 By Zachary Brennan - Published 06 September 2016

In just its third untitled letter of the year (and the first in almost five months), the US Food and Drug Administration (FDA) on Tuesday called out Jazz Pharmaceuticals subsidiary Celator Pharmaceuticals for promoting an investigational drug in a panel at the American Society of Clinical Oncology’s (ASCO) annual meeting in June.

Categories: News, US, FDA, Biologics and biotechnology, Crisis management, Drugs, Due Diligence, Regulatory intelligence, Regulatory strategy, Submission and registration

Tags: ASCO, Jazz Pharmaceuticals, OPDP, untitled letter

Regulatory Recon: FDA Approves Allergan Combo Therapy; Biden to Launch Database to Advance Cancer Research and More From ASCO 2016 (6 June 2016) By Zachary Brennan - Published 06 June 2016

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.

Categories: News, Asia, Europe, Latin America and Caribbean, US, EC, EMA, FDA, Health Canada, MHRA, Biologics and biotechnology, Clinical, Drugs, Government affairs

Tags: Regulatory Reconnaissance, Regulatory, Links, News, Regulatory News, Regulatory Intelligence, FDA News, EMA News, ASCO 2016